These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3628443)

  • 1. Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding.
    Angel I; Stivers JA; Paul SM; Crawley JN
    Pharmacol Biochem Behav; 1987 Jun; 27(2):291-7. PubMed ID: 3628443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of [3H]mazindol binding to subhypothalamic areas: involvement in glucoprivic feeding.
    Angel I; Kiss A; Stivers JA; Skirboll L; Crawley JN; Paul SM
    Brain Res Bull; 1986 Dec; 17(6):873-7. PubMed ID: 3801941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the anorectic drug recognition site during glucoprivic feeding.
    Angel I; Hauger RL; Giblin BA; Paul SM
    Brain Res Bull; 1992 Feb; 28(2):201-7. PubMed ID: 1317740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of fenfluramine and other anorectic agents in different feeding and drinking paradigms in rats.
    Rowland NE; Antelman SM; Bartness TJ
    Life Sci; 1985 Jun; 36(24):2295-300. PubMed ID: 4010458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of the anorexic effects of fenfluramine and amphetamine following intrahypothalamic injection.
    Blundell JE; Leshem MB
    Br J Pharmacol; 1973 Jan; 47(1):183-5. PubMed ID: 4717019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eating caused by neuropeptide-Y injection in the paraventricular hypothalamus: response to (+)-fenfluramine and (+)-amphetamine in rats.
    Bendotti C; Garattini S; Samanin R
    J Pharm Pharmacol; 1987 Nov; 39(11):900-3. PubMed ID: 2892914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
    Shukla R; MacKenzie-Taylor D; Rech RH
    Psychopharmacology (Berl); 1990; 100(1):115-8. PubMed ID: 2296618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central action of anorexic agents: effects of amphetamine and fenfluramine in rats with lateral hypothalamic lesions.
    Blundell JE; Leshem MB
    Eur J Pharmacol; 1974 Sep; 28(1):81-8. PubMed ID: 4609778
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview of adrenergic anorectic agents.
    Wellman PJ
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):193S-198S. PubMed ID: 1309478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the non-amphetaminergic anorexiant, mazindol, on neuronal activity and hypothalamic control of gastric acid secretion in rats.
    Shiraishi T
    Int J Obes; 1985; 9(4):285-97. PubMed ID: 3905642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of anorectic agents in rats bearing the Walker-256 tumor.
    Maickel RP; Johnson K; Kinney DR
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):421-4. PubMed ID: 3438577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance and cross tolerance to the anorexigenic effect of appetite suppressants in rats.
    Opitz K
    Int J Obes; 1978; 2(1):59-68. PubMed ID: 711356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of three anorectic drugs on central catecholamine levels and synthesis in the Zucker rat.
    Orosco M; Bremond J; Jacquot C; Cohen Y
    Gen Pharmacol; 1983; 14(3):337-42. PubMed ID: 6873624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-D-aspartate lesions of the lateral hypothalamus do not reduce amphetamine or fenfluramine anorexia but enhance the acquisition of eating in response to tail pinch in the rat.
    Clark JM; Clark AJ; Winn P
    Psychopharmacology (Berl); 1992; 109(3):331-7. PubMed ID: 1365634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic neuropeptides could mediate the anorectic effects of fenfluramine.
    Max JP; Thystere P; Chapleur-Chateau M; Burlet A; Nicolas JP; Burlet C
    Neuroreport; 1994 Oct; 5(15):1925-8. PubMed ID: 7841378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic monoamines measured by microdialysis in rats treated with 2-deoxy-glucose or d-fenfluramine.
    Shimizu H; Bray GA
    Physiol Behav; 1989 Nov; 46(5):799-807. PubMed ID: 2628991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The time-structure of the anorectic effect of satietin.
    Sándor G; Knoll J
    Physiol Behav; 1985 May; 34(5):851-3. PubMed ID: 4034724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
    Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions.
    Ragnauth A; Ruegg H; Bodnar RJ
    Brain Res; 1997 Aug; 767(1):8-16. PubMed ID: 9365010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.